Known targets — ChEMBL curated mechanism
SLC6A2SLC6A3SSTR1SSTR2SSTR3SSTR5
The experimentally established mechanism targets of Aspartic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 4/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | CPT2 | P23786 | 1/20 | 0.41 |
| ▸ | CPT1A | P50416 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.30 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.30 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.30 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
| ▸ | GSR | P00390 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aspartic Acid SCHEMBL17350095 | 1.00 | CA4 (0.46) | CA4CTSLCPT2CPT1ACA2 | |
| Aspartic Acid SCHEMBL10341217 | 1.00 | CA4 (0.46) | CA4CTSLCPT2CPT1ACA2 | |
| Aspartic Acid SCHEMBL10341215 | 1.00 | CA4 (0.46) | CA4CTSLCPT2CPT1ACA2 | |
| Aspartic Acid SCHEMBL376348 | 0.97 | CA4 (0.48) | CA4CTSLCPT2CPT1ACA2 | |
| Aspartic Acid SCHEMBL29497343 | 0.97 | CA4 (0.48) | CA4CTSLCPT2CPT1ACA2 | |
| Aspartic Acid SCHEMBL376346 | 0.97 | CA4 (0.48) | CA4CTSLCPT2CPT1ACA2 | |
| Aspartic Acid SCHEMBL30486028 | 0.97 | CA4 (0.48) | CA4CTSLCPT2CPT1ACA2 | |
| Aspartic Acid SCHEMBL23322527 | 0.95 | CA4 (0.46) | CA4CTSLCPT2CPT1ACA2 | |
| Aspartic Acid SCHEMBL10599628 | 0.95 | CA4 (0.46) | CA4CTSLCPT2CPT1ACA2 | |
| Aspartic Acid SCHEMBL4018860 | 0.95 | CA4 (0.46) | CA4CTSLCPT2CPT1ACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12583873-B2 | Amino acid mineral complex having immunopotentiating activity and composition for foods, pharmaceuticals, or feeds comprising same | BTN CO., LTD. (KR) | 2026-03-24 | — | — | US | claimed |
| EP-3828187-B1 | AMINO ACID MINERAL COMPLEX HAVING IMMUNOPOTENTIATING ACTIVITY AND COMPOSITION FOR FOODS, PHARMACEUTICALS, OR FEEDS COMPRISING SAME | BTN CO LTD (KR) | 2025-10-22 | — | — | EP | claimed |
| US-20210347788-A1 | AMINO ACID MINERAL COMPLEX HAVING IMMUNOPOTENTIATING ACTIVITY AND COMPOSITION FOR FOODS, PHARMACEUTICALS, OR FEEDS COMPRISING SAME | BTN CO., LTD. (KR) | 2021-11-11 | — | — | US | claimed |
| EP-3828187-A1 | AMINO ACID MINERAL COMPLEX HAVING IMMUNOPOTENTIATING ACTIVITY AND COMPOSITION FOR FOODS, PHARMACEUTICALS, OR FEEDS COMPRISING SAME | BTN Co., Ltd. (KR) | 2021-06-02 | — | — | EP | claimed |
| CN-112424208-A | Amino acid-mineral complex having immunopotentiating activity and food, pharmaceutical or feed composition comprising the same | 比特恩有限公司 | 2021-02-26 | — | — | CN | claimed |
| US-12583873-B2 | Amino acid mineral complex having immunopotentiating activity and composition for foods, pharmaceuticals, or feeds comprising same | BTN CO., LTD. (KR) | 2026-03-24 | — | — | US | disclosed |
| EP-3828187-B1 | AMINO ACID MINERAL COMPLEX HAVING IMMUNOPOTENTIATING ACTIVITY AND COMPOSITION FOR FOODS, PHARMACEUTICALS, OR FEEDS COMPRISING SAME | BTN CO LTD (KR) | 2025-10-22 | — | — | EP | disclosed |
| US-20210347788-A1 | AMINO ACID MINERAL COMPLEX HAVING IMMUNOPOTENTIATING ACTIVITY AND COMPOSITION FOR FOODS, PHARMACEUTICALS, OR FEEDS COMPRISING SAME | BTN CO., LTD. (KR) | 2021-11-11 | — | — | US | disclosed |
| EP-3828187-A1 | AMINO ACID MINERAL COMPLEX HAVING IMMUNOPOTENTIATING ACTIVITY AND COMPOSITION FOR FOODS, PHARMACEUTICALS, OR FEEDS COMPRISING SAME | BTN Co., Ltd. (KR) | 2021-06-02 | — | — | EP | disclosed |
| CN-112424208-A | Amino acid-mineral complex having immunopotentiating activity and food, pharmaceutical or feed composition comprising the same | 比特恩有限公司 | 2021-02-26 | — | — | CN | disclosed |
| US-9216184-B1 | Agent and method for increasing testosterone level in a body | Lunada Biomedical, LLC (US) | 2015-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210347788-A1 | AMINO ACID MINERAL COMPLEX HAVING IMMUNOPOTENTIATING ACTIVITY AND COMPOSITION FOR FOODS, PHARMACEUTICALS, OR FEEDS COMPRISING SAME | BCAT2, BCAT1, MAX | CA4 555/4885CTSL 3401/4885CPT2 4720/4885 |
| US-12583873-B2 | Amino acid mineral complex having immunopotentiating activity and composition for foods, pharmaceuticals, or feeds comprising same | SLC7A1, SLC39A7, SLC30A5 | CA4 858/4885CTSL 2559/4885CPT2 4303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.